PRESS RELEASES Clear Filters January 7, 2026 Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week Read More January 6, 2026 Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287 Read More December 18, 2025 Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease Read More December 18, 2025 Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease Read More November 20, 2025 Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 Read More November 12, 2025 Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update Read More View More IN THE NEWS Clear Filters December 18, 2025 Early signals stack up: Two small molecules activate GCase in Parkinson’s https://www.biocentury.com/article/657912/early-signals-stack-up-two-small-molecules-activate-gcase-in-parkinson-s Read More December 18, 2025 Two Molecules Show Potential in Targeting GCase Activity for Parkinson’s Disease Treatment https://www.geneonline.com/two-molecules-show-potential-in-targeting-gcase-activity-for-parkinsons-disease-treatment/ Read More December 13, 2025 AI and Physics-Based Modeling Identifies a New Parkinson’s Disease Drug https://www.the-scientist.com/ai-and-physics-based-modeling-identifies-a-new-parkinson-s-disease-drug-73851 Read More October 9, 2025 In the clinic for Oct. 9, 2025 https://www.bioworld.com/articles/724982-in-the-clinic-for-oct-9-2025 Read More October 9, 2025 Allosteric small molecule therapies in PD, with Gene Mack https://pharmaphorum.com/rd/allosteric-small-molecule-therapies-pd-gene-mack Read More October 8, 2025 Early data suggest GT-02287 slows Parkinson’s disease https://www.ddw-online.com/early-data-suggest-gt-02287-slows-parkinsons-disease-37433-202510/ Read More View More EVENTS Clear Filters January 6, 2026 Parkinson’s Disease KOL Event: Understanding GCase Substrates in Parkinson’s Disease – Perspectives on Biomarkers and Disease Modification Read More View More
